GlassScriptPhysician profile
Ashley M Springer
NPI 1811387442
$42,718.22
in general payments reported to CMS, 2019-2025
87 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,778 · 2022: $6,360 · 2023: $8,153 · 2024: $11K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Food and Beverage: $12K · Consulting Fee: $938 · Travel and Lodging: $452 · Education: $409 · Long Term Medical Supply Or Device Loan: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,750.00 |
| Food and Beverage | $11,865.25 |
| Consulting Fee | $937.50 |
| Travel and Lodging | $452.12 |
| Education | $409.33 |
| Long Term Medical Supply Or Device Loan | $166.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $25,404.34 | 2021-2025 | Tagrisso, Imfinzi, Enhertu |
| Pfizer INC. | $1,539.28 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,238.70 | 2021-2025 | |
| Janssen Biotech, INC. | $1,129.58 | 2021-2025 | Erleada, Tecvayli, Darzalex |
| Incyte Corporation | $774.41 | 2021-2025 | Jakafi, Monjuvi, Niktimvo |
| Emd Serono, INC. | $653.37 | 2021-2025 | Tepmetko |
| Abbvie INC. | $624.28 | 2021-2025 | |
| Caris Mpi, INC. | $578.82 | 2025 | Mi Cancer Seek |
| Janssen Scientific Affairs, LLC | $577.24 | 2024-2025 | Rybrevant |
| Lilly USA, LLC | $515.60 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Amgen INC. | $497.05 | 2021-2025 | Imdelltra (Amg757), Kyprolis, Xgeva |
| E.R. Squibb & Sons, L.L.C. | $459.17 | 2021-2025 | Opdivo, Opdualag, Reblozyl |
| Genzyme Corporation | $425.73 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $404.20 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Daiichi Sankyo INC. | $387.48 | 2021-2025 | Enhertu, Vanflyta |
Show all 87 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $382.19 | 2021-2025 | Libtayo, Lynozyfic |
| Genentech USA, INC. | $364.33 | 2021-2025 | Venclexta, Gazyva, Lunsumio |
| Seagen INC. | $303.80 | 2021-2023 | Adcetris, Padcev |
| Pharmacyclics LLC, An Abbvie Company | $276.19 | 2021-2023 | Imbruvica, Epkinly |
| Eisai INC. | $272.07 | 2021-2025 | |
| Ipsen Biopharmaceuticals, INC | $248.26 | 2021-2025 | Onivyde, Somatuline Depot, Tazverik |
| Glaxosmithkline, LLC. | $193.91 | 2021-2025 | Ojjaara, Jemperli, Zejula |
| Astellas Pharma US INC | $188.67 | 2021-2025 | Padcev, Xtandi, Vyloy |
| Kyowa Kirin, INC. | $183.26 | 2022-2025 | Poteligeo |
| Takeda Pharmaceuticals U.S.A., INC. | $180.80 | 2022-2025 | Ninlaro, Fruzaqla, Vonvendi |
| Deciphera Pharmaceuticals INC. | $175.42 | 2021-2025 | Qinlock, Tgct |
| Sobi, INC | $167.49 | 2022-2025 | |
| Adc Therapeutics America, INC. | $166.84 | 2022 | |
| Celgene Corporation | $166.63 | 2022-2025 | Reblozyl, Pomalyst |
| Rigel Pharmaceuticals, INC. | $163.01 | 2022-2025 | Rezlidhia, Tavalisse, Gavreto |
| Kite Pharma, INC. | $144.90 | 2021-2023 | Yescarta |
| Blueprint Medicines Corporation | $144.14 | 2021-2025 | Ayvakit |
| Gilead Sciences, INC. | $143.62 | 2021-2024 | Trodelvy |
| Exelixis INC. | $137.67 | 2023-2025 | Cabometyx |
| Jazz Pharmaceuticals INC. | $136.35 | 2022-2025 | |
| Puma Biotechnology, INC. | $134.91 | 2021-2024 | |
| Aveo Pharmaceuticals, INC. | $132.44 | 2022-2025 | Fotivda |
| Beigene USA, INC. | $131.03 | 2022-2024 | Brukinsa |
| Cardinal Health 108 LLC | $128.36 | 2022 | |
| Servier Pharmaceuticals LLC | $127.81 | 2022-2025 | |
| Coherus Oncology, INC. | $121.83 | 2022-2024 | |
| Taiho Oncology, INC. | $116.39 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.20 | 2023-2025 | Gilotrif |
| Tempus Ai, INC | $110.55 | 2024-2025 | Xt Cdx |
| Novocure INC. | $110.48 | 2021-2025 | Optune, Optune Gio |
| Eusa Pharma (US) LLC | $108.68 | 2021-2022 | |
| Stemline Therapeutics INC. | $98.87 | 2023-2025 | Orserdu |
| Array Biopharma INC | $98.15 | 2021-2025 | Braftovi, Xalkori, Lorbrena |
| Karyopharm Therapeutics INC. | $97.96 | 2021-2024 | Xpovio |
| Sanofi-Aventis U.S. LLC | $96.00 | 2023 | |
| Tersera Therapeutics LLC | $92.38 | 2023-2025 | Zoladex |
| Alexion Pharmaceuticals, INC. | $90.61 | 2023-2025 | Ultomiris |
| Novo Nordisk INC | $84.89 | 2023-2025 | Rebinyn, Novoeight, Tretten |
| Springworks Therapeutics, INC. | $80.37 | 2024-2025 | Ogsiveo |
| Mirati Therapeutics, INC. | $78.14 | 2023-2024 | Krazati |
| Azurity Pharmaceuticals, INC. | $72.97 | 2024-2025 | Vivimusta, Danziten |
| Genmab U.S., INC. | $71.94 | 2023-2025 | Epkinly |
| Acrotech Biopharma INC. | $68.58 | 2021-2025 | Beleodaq, Ryzneuta |
| Immunitybio, INC. | $63.22 | 2025 | |
| Apellis Pharmaceuticals, INC. | $60.41 | 2023-2024 | Empaveli |
| Spectrum Pharmaceuticals INC. | $58.48 | 2023-2025 | Rolvedon |
| Menarini Silicon Biosystems, INC. | $53.47 | 2025 | |
| Pharmacosmos Therapeutics INC. | $50.83 | 2025 | Monoferric |
| Beone Medicines USA, INC. | $49.82 | 2025 | Brukinsa |
| Sun Pharmaceutical Industries INC. | $48.56 | 2023-2024 | Yonsa, Odomzo |
| Celltrion USA INC. | $47.20 | 2023-2024 | Vegzelma |
| Fennec Pharmaceuticals, INC. | $45.66 | 2024-2025 | Fyarro, Pedmark |
| Aadi Bioscience, INC. | $44.98 | 2024 | Fyarro |
| Alnylam Pharmaceuticals INC. | $43.43 | 2024-2025 | Givlaari |
| Agios Pharmaceuticals, INC. | $42.05 | 2024 | Pyrukynd |
| Dova Pharmaceuticals | $35.37 | 2021 | |
| Syndax Pharmaceuticals, INC. | $34.64 | 2025 | |
| Cti Biopharma Corp. | $28.55 | 2022 | |
| Dendreon Pharmaceuticals LLC | $26.21 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $25.61 | 2022 | |
| Ferring Pharmaceuticals INC. | $24.84 | 2025 | Adstiladrin |
| Recordati_rare_diseases_inc. | $24.66 | 2024 | Sylvant |
| G1 Therapeutics, INC. | $24.52 | 2022 | |
| Pharmaessentia USA Corporation | $24.32 | 2025 | Besremi |
| Mylan Institutional INC. | $23.56 | 2023 | Ogivri, Fulphila |
| Clovis Oncology, INC. | $23.47 | 2021 | |
| Epizyme, INC. | $20.43 | 2021 | |
| Accord Healthcare, INC. | $18.68 | 2025 | |
| Adaptive Biotechnologies Corporation | $18.56 | 2023 | Clonoseq |
| Chiesi USA, INC. | $17.53 | 2025 | Ferriprox |
| Horizon Therapeutics Plc | $16.59 | 2021 | |
| Janssen Pharmaceuticals, INC | $9.23 | 2021 |
Drugs and devices associated with these payments
Tagrisso $10KImfinzi $5,203Mi Cancer Seek $579Rybrevant $577Xtandi $575Enhertu $441Erleada $363Talzenna $337Orgovyx $307Keytruda $292Elrexfio $275Epkinly $260Jakafi $260Tecvayli $236Ibrance $233Libtayo $220Imbruvica $212Kisqali $208Venclexta $193Adcetris $190Darzalex $188Verzenio $175Brukinsa $164Jaypirca $160Ayvakit $153Reblozyl $148Rezlidhia $141Tavalisse $141Opdivo $139Cabometyx $138Padcev $138Monjuvi $135Niktimvo $134Poteligeo $124Jevtana $124Calquence $124Pluvicto $122Carvykti $122Lenvima $120Vanflyta $114Zepzelca $113Qinlock $112Paxlovid $112Lynparza $111Onivyde $110Talvey $110Pemazyre $106Welireg $106Fotivda $106Ninlaro $105Orserdu $98.87Sarclisa $97.28Udenyca $96.83Lutathera $96.77Zoladex $92.38Tukysa $90.67Ultomiris $90.61Tepmetko $89.87Scemblix $88.38Gavreto $87.29Comirnaty $83.23Bosulif $81.16Braftovi $80.97Tibsovo $80.57Ogsiveo $80.37Retevmo $78.36Krazati $78.14Xt Cdx $71.09Ojjaara $69.90Fyarro $69.47Vonjo $66.89Fabhalta $65.61Anktiva $63.22Doptelet $62.07Optune $61.82Empaveli $60.41Gilotrif $59.72Rolvedon $58.48Lunsumio $56.47Gazyva $56.47Emrelis $54.01Somatuline Depot $53.99Polivy $53.85Cellsearch $53.47Xpovio $52.45Xalkori $51.37Lorbrena $51.37Mektovi $51.37Monoferric $50.83Hympavzi $48.75Yonsa $48.56Odomzo $48.56Besponsa $47.94Optune Gio $47.94Lonsurf $47.32Inqovi $47.32Vegzelma $47.20Tecentriq $46.26Novoeight $45.93Rebinyn $45.93
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Springer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.